Wook Kim
Director of Finance/CFO bei HLB GLOBAL CO., LTD.
Profil
Wook Kim is currently the Chief Financial Officer & Director at HLB GLOBAL Co., Ltd.
and also holds a Director position at HLB Co., Ltd.
He previously worked as a Director at Elevar Therapeutics, Inc. Mr. Kim completed his undergraduate degree at Korea University.
Aktive Positionen von Wook Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| HLB CO., LTD. | Director/Board Member | - |
| HLB GLOBAL CO., LTD. | Director of Finance/CFO | 01.08.2018 |
Ehemalige bekannte Positionen von Wook Kim
| Unternehmen | Position | Ende |
|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Director/Board Member | - |
Ausbildung von Wook Kim
| Korea University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HLB GLOBAL CO., LTD. | Energy Minerals |
| HLB CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
